Related Experiment Video
Updated: May 6, 2026
07:54
Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
Published on: August 29, 2018
8.2K
Transcriptome network analysis of potential candidate genes for heart failure.
1Department of Cardiology, Daping Hospital, Third Military Medical University Cardiology, Chongqing, China.
Genetics and Molecular Research : GMR
|November 14, 2013
Summary
This study identifies key gene networks and transcription factors involved in dilated cardiomyopathy and heart failure. These findings offer new targets for treating heart failure and related inflammatory conditions.
Area of Science:
- Genomics
- Cardiovascular Biology
- Bioinformatics
Background:
- Dilated cardiomyopathy is a significant cause of heart failure.
- Identifying molecular mechanisms underlying heart failure is crucial for developing effective treatments.
Purpose of the Study:
- To develop a transcriptome network for dilated cardiomyopathy.
- To identify and modulate transcription factors and genes involved in heart failure.
- To explore regulatory relationships in heart failure pathogenesis.
Main Methods:
- Utilized GSE4172 microarray data to identify genes related to dilated cardiomyopathy.
- Mapped differentially expressed genes to biological pathways.
- Constructed a gene regulation network to analyze transcription factor-pathway interactions.
Main Results:
- Identified known and novel transcription factors and target genes associated with heart failure.
- Discovered CCAAT/enhancer-binding protein delta and JunB as key players in inflammatory cardiomyopathy.
- Transcriptome network analysis successfully identified candidate genes for heart failure.
Conclusions:
- Transcriptome network analysis is a powerful tool for identifying disease-related pathways and candidate genes.
- This approach is well-suited for analyzing microarray data in heart failure research.
- The identified networks and factors provide potential therapeutic targets for heart failure.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
01:29Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
01:17Pathophysiology of Heart Failure
5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129